Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region

American Journal of Human Genetics

Volumn 95, Issue 4, 2014, Pages 462-471

  Skibola, Christine F ^a,b   Berndt, Sonja I ^c   Vijai, Joseph ^d   Conde, Lucia ^a,b   Wang, Zhaoming ^c   Yeager, Meredith ^c   De Bakker, Paul I W ^e   Birmann, Brenda M ^f   Vajdic, Claire M ^g   Foo, Jia Nee ^h   Bracci, Paige M ⁱ   Vermeulen, Roel C H ^e,j   Slager, Susan L ^k   De Sanjose, Silvia ^l,m   Wang, Sophia S ⁿ   Linet, Martha S ^c   Salles, Gilles ^o,p,q   Lan, Qing ^c   Severi, Gianluca ^r,s,t   Hjalgrim, Henrik ^u   Lightfoot, Tracy ^v   Melbye, Mads ^u,w   Gu, Jian ^x   Ghesquières, Hervé ^q,y   Link, Brian K ^z   Morton, Lindsay M ^c   Holly, Elizabeth A ⁱ   Smith, Alex ^v   Tinker, Lesley F ^aa   Teras, Lauren R ^ab   Kricker, Anne ^ac   Becker, Nikolaus ^ad   Purdue, Mark P ^c   Spinelli, John J ^ae,af   Zhang, Yawei ^ag   Giles, Graham G ^s,t   Vineis, Paolo ^r,ah   Monnereau, Alain ^ai,aj   Bertrand, Kimberly A ^f,ak   Albanes, Demetrius ^c   Zeleniuch Jacquotte, Anne ^al   Gabbas, Attilio ^am   Chung, Charles C ^c   Burdett, Laurie ^c   Hutchinson, Amy ^c   Lawrence, Charles ^an   Montalvan, Rebecca ^an   Liang, Liming ^ak   Huang, Jinyan ^ak   Ma, Baoshan ^ak,ao   Liu, Jianjun ^h   Adami, Hans Olov ^ak,ap   Glimelius, Bengt ^aq,ar   Ye, Yuanqing ^x   Nowakowski, Grzegorz S ^k   Dogan, Ahmet ^d   Thompson, Carrie A ^k   Habermann, Thomas M ^k   Novak, Anne J ^k   Liebow, Mark ^k   Witzig, Thomas E ^k   Weiner, George J ^z   Schenk, Maryjean ^as   Hartge, Patricia ^c   De Roos, Anneclaire J ^aa,at   Cozen, Wendy ^au,av   Zhi, Degui ^aw   Akers, Nicholas K ^b   Riby, Jacques ^a,b   Smith, Martyn T ^b   Lacher, Mortimer ^d   Villano, Danylo J ^d   Maria, Ann ^d   Roman, Eve ^v   Kane, Eleanor ^v   Jackson, Rebecca D ^ax   North, Kari E ^ay,az   Diver, W Ryan ^ab   Turner, Jenny ^ba,bb   Armstrong, Bruce K ^ac   Benavente, Yolanda ^l,m   Boffetta, Paolo ^bc   Brennan, Paul ^bd   Foretova, Lenka ^be   Maynadie, Marc ^bf   Staines, Anthony ^bg   McKay, James ^bd   Brooks Wilson, Angela R ^ae,bh   Zheng, Tongzhang ^ag   Holford, Theodore R ^ag   Chamosa, Saioa ^bi   Kaaks, Rudolph ^ad   Kelly, Rachel S ^ah,ak   Ohlsson, Bodil ^bj   Travis, Ruth C ^bk   Weiderpass, Elisabete ^ap,bl,bm,bn   Clavel, Jacqueline ^ai   Giovannucci, Edward ^f,ak   Kraft, Peter ^ak   Virtamo, Jarmo ^bo   Mazza, Patrizio ^bp   Cocco, Pierluigi ^am   Ennas, Maria Grazia ^am   Chiu, Brian C H ^bq   Fraumeni, Joseph F ^c   Nieters, Alexandra ^br   Offit, Kenneth ^d   Wu, Xifeng ^x   Cerhan, James R ^k   Smedby, Karin E ^ap   Chanock, Stephen J ^c   Rothman, Nathaniel ^c   more..

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

^h GENOME INSTITUTE OF SINGAPORE   (Singapore)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UTRECHT UNIVERSITY   (Netherlands)

^k MAYO CLINIC   (United States)

^l BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^m CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

ⁿ CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^o HOSPICES CIVILS DE LYON   (France)

^p UNIVERSITÉ LYON 1   (France)

^q CNRS   (France)

^r Human Genetics Foundation   (Italy)

^s CANCER EPIDEMIOLOGY CENTRE   (Australia)

^t UNIVERSITY OF MELBOURNE   (Australia)

^u STATENS SERUM INSTITUT   (Denmark)

^v UNIVERSITY OF YORK   (United Kingdom)

^w STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^y CENTRE LÉON BÉRARD   (France)

^z UNIVERSITY OF IOWA   (United States)

^aa Fred Hutchinson Cancer Research Center   (United States)

^ab AMERICAN CANCER SOCIETY   (United States)

^ac UNIVERSITY OF SYDNEY   (Australia)

^ad GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^ae BRITISH COLUMBIA CANCER AGENCY   (Canada)

^af UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^ag YALE UNIVERSITY   (United States)

^ah IMPERIAL COLLEGE LONDON   (United Kingdom)

^ai CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^aj INSTITUT BERGONIÉ   (France)

^ak HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^al NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^am UNIVERSITY OF CAGLIARI   (Italy)

^an WESTAT   (United States)

^ao DALIAN MARITIME UNIVERSITY   (China)

^ap KAROLINSKA INSTITUTE   (Sweden)

^aq KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ar UPPSALA UNIVERSITY   (Sweden)

^as WAYNE STATE UNIVERSITY   (United States)

^at DREXEL UNIVERSITY   (United States)

^au UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^av UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^aw UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^ax OHIO STATE UNIVERSITY   (United States)

^ay The University of North Carolina at Chapel Hill   (United States)

^az UNIVERSITY OF NORTH CAROLINA   (United States)

^ba MACQUARIE UNIVERSITY   (Australia)

^bb DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^bc MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^bd INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^be MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^bf DIJON UNIVERSITY HOSPITAL   (France)

^bg DUBLIN CITY UNIVERSITY   (Ireland)

^bh SIMON FRASER UNIVERSITY   (Canada)

^bi BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^bj LUND UNIVERSITY   (Sweden)

^bk UNIVERSITY OF OXFORD   (United Kingdom)

^bl UNIVERSITY OF TROMSØ   (Norway)

^bm CANCER REGISTRY OF NORWAY   (Norway)

^bn FOLKHÄLSAN RESEARCH CENTER   (Finland)

^bo NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^bp Ospedale Nord   (Italy)

^bq UNIVERSITY OF CHICAGO   (United States)

^br UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR5; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; PANCYTOMA VARIANT TRANSLOCATION 1 PROTEIN; PARTNER IN LIPOMA PROTEIN; PEPTIDES AND PROTEINS; PROTEIN BCL 2; SOLUTE CARRIER 14A2; TRANSCRIPTION FACTOR ETS 1; UNCLASSIFIED DRUG; TUMOR MARKER;

ALLELE; ARTICLE; CHROMOSOME 17; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; METHYLATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN CHROMOSOME;

ALLELES; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HLA ANTIGENS; HUMANS; LYMPHOMA, FOLLICULAR; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR MARKERS, BIOLOGICAL;

EID: 84921517901     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2014.09.004     Document Type: Article

References (35)

1. 1000 Genomes, http://browser.1000genomes.org
2. ChroMoS, http://epicenter.immunbio.mpg.de/services/chromos
3. Gene Expression Omnibus (GEO), http://www.ncbi.nlm.nih.gov/geo/
4. glu-genetics, https://code.google.com/p/glu-genetics/
5. HaploReg, http://www.broadinstitute.org/mammals/haploreg/haploreg.php
6. IMPUTE2, http://mathgen.stats.ox.ac.uk/impute/impute-v2.html
7. Online Mendelian Inheritance in Man (OMIM), http://www.omim.org/
8. PLINK, http://pngu.mgh.harvard.edu/~purcell/plink/
9. SNP2HLA, https://www.broadinstitute.org/mpg/snp2hla/
10. snptest, https://mathgen.stats.ox.ac.uk/genetics-software/snptest/old/snptest.html
11. Link, B.K., Maurer, M.J., Nowakowski, G.S., Ansell, S.M., Macon, W.R., Syrbu, S.I., Slager, S.L., Thompson, C.A., Inwards, D.J., Johnston, P.B., et al. (2013). Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource. J. Clin. Oncol. 31, 3272-3278.
12. Tan, D., Horning, S.J., Hoppe, R.T., Levy, R., Rosenberg, S.A., Sigal, B.M., Warnke, R.A., Natkunam, Y., Han, S.S., Yuen, A., et al. (2013). Improvements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades: the Stanford University experience. Blood 122, 981-987.
13. Smedby, K.E., Foo, J.N., Skibola, C.F., Darabi, H., Conde, L., Hjalgrim, H., Kumar, V., Chang, E.T., Rothman, N., Cerhan, J.R., et al. (2011). GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 7, e1001378.
14. Conde, L., Halperin, E., Akers, N.K., Brown, K.M., Smedby, K.E., Rothman, N., Nieters, A., Slager, S.L., Brooks-Wilson, A., Agana, L., et al. (2010). Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat. Genet. 42, 661-664.
15. Skibola, C.F., Bracci, P.M., Halperin, E., Conde, L., Craig, D.W., Agana, L., Iyadurai, K., Becker, N., Brooks-Wilson, A., Curry, J.D., et al. (2009). Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat. Genet. 41, 873-875.
16. Vijai, J., Kirchhoff, T., Schrader, K.A., Brown, J., Dutra-Clarke, A.V., Manschreck, C., Hansen, N., Rau-Murthy, R., Sarrel, K., Przybylo, J., et al. (2013). Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. PLoS Genet. 9, e1003220.
17. Skibola, C.F., Conde, L., Foo, J.N., Riby, J., Humphreys, K., Sillé, F.C., Darabi, H., Sanchez, S., Hjalgrim, H., Liu, J., et al. (2012). A meta-analysis of genome-wide association studies of follicular lymphoma. BMC Genomics 13, 516.
18. Wang, Z., Jacobs, K.B., Yeager, M., Hutchinson, A., Sampson, J., Chatterjee, N., Albanes, D., Berndt, S.I., Chung, C.C., Diver, W.R., et al. (2012). Improved imputation of common and uncommon SNPs with a new reference set. Nat. Genet. 44, 6-7.
19. Abecasis, G.R., Altshuler, D., Auton, A., Brooks, L.D., Durbin, R.M., Gibbs, R.A., Hurles, M.E., and McVean, G.A.; 1000 Genomes Project Consortium (2010). A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073.
20. Howie, B.N., Donnelly, P., and Marchini, J. (2009). A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529.
21. Ward, L.D., and Kellis, M. (2012). HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40 (Database issue), D930-D934.
22. Barenboim, M., and Manke, T. (2013). ChroMoS: an integrated web tool for SNP classification, prioritization and functional interpretation. Bioinformatics 29, 2197-2198.
23. Ernst, J., Kheradpour, P., Mikkelsen, T.S., Shoresh, N., Ward, L.D., Epstein, C.B., Zhang, X., Wang, L., Issner, R., Coyne, M., et al. (2011). Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49.
24. Consortium, E.P., Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C., and Snyder, M.; ENCODE Project Consortium (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74.
25. Jia, X., Han, B., Onengut-Gumuscu, S., Chen, W.M., Concannon, P.J., Rich, S.S., Raychaudhuri, S., and de Bakker, P.I. (2013). Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE 8, e64683.
26. Wang, S.S., Abdou, A.M., Morton, L.M., Thomas, R., Cerhan, J.R., Gao, X., Cozen, W., Rothman, N., Davis, S., Severson, R.K., et al. (2010). Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood 115, 4820-4823.
27. Skibola, C.F., Akers, N.K., Conde, L., Ladner, M., Hawbecker, S.K., Cohen, F., Ribas, F., Erlich, H.A., Goodridge, D., Trachtenberg, E.A., et al. (2012). Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma. Tissue Antigens 79, 279-286.
28. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J., and Sham, P.C. (2007). PLINK: a tool set for wholegenome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575.
29. Foo, J.N., Smedby, K.E., Akers, N.K., Berglund, M., Irwan, I.D., Jia, X., Li, Y., Conde, L., Darabi, H., Bracci, P.M., et al. (2013). Coding variants at hexa-allelic amino acid 13 of HLA-DRB1 explain independent SNP associations with follicular lymphoma risk. Am. J. Hum. Genet. 93, 167-172.
30. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
31. Rapin, N., Hoof, I., Lund, O., and Nielsen, M. (2010). The MHC motif viewer: a visualization tool for MHC binding motifs. Curr. Protoc. Immunol. Unit 18, 17.
32. Díaz, G., Amicosante, M., Jaraquemada, D., Butler, R.H., Guillén, M.V., Sánchez, M., Nombela, C., and Arroyo, J. (2003). Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int. Immunol. 15, 565-576.
33. Taylor, G.M., Gokhale, D.A., Crowther, D., Woll, P.J., Harris, M., Ryder, D., Ayres, M., and Radford, J.A. (1999). Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes. Br. J. Cancer 80, 1405-1411.
34. Conde, L., Bracci, P.M., Richardson, R., Montgomery, S.B., and Skibola, C.F. (2013). IntegratingGWAS and expression data for functional characterization of disease-associated SNPs: an application to follicular lymphoma. Am. J. Hum. Genet. 92, 126-130.
35. Sillé, F.C., Conde, L., Zhang, J., Akers, N.K., Sanchez, S., Maltbaek, J., Riby, J.E., Smith, M.T., and Skibola, C.F. (2014). Follicular lymphoma-protective HLA class II variants correlate with increased HLA-DQB1 protein expression. Genes Immun. 15, 133-136.